C41H41N5O8 Adenosine, N-benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′- O-(2-methoxyethyl)- (9CI, ACI)

Canonical SMILES O=C(NC1=NC=NC2=C1N=CN2C3OC(COC(C=4C=CC=CC4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6) )C(O)C3OCCOC)C=7C=CC=CC7
GWênau Isomerig
C(OC[C@H]1O[C@H]([C@H](OCCOC)[C@@H]1O)N2C=3C(N=C2)=C(NC(=O)C4=CC =CC=C4)N=CN3)(C5=CC=C(OC)C=C5)(C6=CC=C(OC)C
=C6)C7=CC=CC=C7
InChI
InChI=1S/C41H41N5O8/c1-49-22-23-52-36-35(47)33(54-40(36)46-26-44-34-37(42-25-43-38(34)) 46)45-39(48)27-10-6-4-7-11-27)24-53- 41(28-12-8-5-9-13-28,29-14-18-31( 50-2)19-15-29)30-16-20-32(51-3)21-17-30/h4-21,25-26,33,35-36,40,47H,22-24H2, 1-3H3, (H,42,43,45,48)/t33-,35-,36-,40-/m1/s1
Allwedd InChI
KEVMXGNDTKPSMC-MUMPVVMASA-N
16 Enwau Eraill ar y Sylwedd hwn
N-Benzoyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-(2-methoxyethyl)adenosine (ACI);17: PN: US20030211606 TUDALEN: 19 hawlio dilyniant;18: PN: US20040005569 TUDALEN: 22 hawlio dilyniant;20: PN: US20040006030 TUDALEN: 23 hawlio dilyniant;20: PN: US20040014047 TUDALEN: 21 hawlio dilyniant;20: PN: US20040014049 TUDALEN: 21 hawlio dilyniant;21: PN: US20040005570 PAG

E: 20 dilyniant hawlio;21: PN: US20040014048 TUDALEN: 21 hawlio dilyniant;21: PN: US20040014050 TUDALEN: 20 hawlio dilyniant;22: PN: US20040005565 TUDALEN: 17- 22 hawlio dilyniant;22: PN: US20040014051 TUDALEN: 23 hawlio dilyniant;23: PN: US20040 014699 TUDALEN: 20 hawlio dilyniant;24: PN: US20040006029 TUDALEN: 23 hawlio dilyniant;24: PN: WO03106645 TUDALEN: 73 hawlio dilyniant;5′-Dimethoxytrityl-2′-O-(2-Methoxyethyl)-N6-benzoyl adenosine;95: PN: US20040005707 TUDALEN: 20 hawlio dilyniant